- Home
- PTCT vs HTGC Comparison
PTCT vs HTGC Comparison
Compare PTCT & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- HTGC
- Stock Information
- Founded
- PTCT 1998
- HTGC 2003
- Country
- PTCT United States
- HTGC United States
- Employees
- PTCT N/A
- HTGC N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- HTGC Investment Managers
- Sector
- PTCT Health Care
- HTGC Finance
- Exchange
- PTCT Nasdaq
- HTGC Nasdaq
- Market Cap
- PTCT 5.3B
- HTGC 3.5B
- IPO Year
- PTCT 2013
- HTGC 2005
- Fundamental
- Price
- PTCT $73.68
- HTGC $18.05
- Analyst Decision
- PTCT Buy
- HTGC Buy
- Analyst Count
- PTCT 17
- HTGC 8
- Target Price
- PTCT $73.24
- HTGC $21.13
- AVG Volume (30 Days)
- PTCT 1.1M
- HTGC 1.2M
- Earning Date
- PTCT 11-04-2025
- HTGC 10-30-2025
- Dividend Yield
- PTCT N/A
- HTGC 10.44%
- EPS Growth
- PTCT N/A
- HTGC N/A
- EPS
- PTCT 8.94
- HTGC 1.75
- Revenue
- PTCT $1,779,150,000.00
- HTGC $516,847,000.00
- Revenue This Year
- PTCT $119.02
- HTGC $8.72
- Revenue Next Year
- PTCT N/A
- HTGC $9.57
- P/E Ratio
- PTCT $8.24
- HTGC $10.27
- Revenue Growth
- PTCT 97.54
- HTGC 4.54
- 52 Week Low
- PTCT $35.95
- HTGC $15.65
- 52 Week High
- PTCT $73.99
- HTGC $22.04
- Technical
- Relative Strength Index (RSI)
- PTCT 76.24
- HTGC 52.35
- Support Level
- PTCT $69.23
- HTGC $17.66
- Resistance Level
- PTCT $73.98
- HTGC $18.11
- Average True Range (ATR)
- PTCT 2.61
- HTGC 0.29
- MACD
- PTCT 0.26
- HTGC 0.08
- Stochastic Oscillator
- PTCT 95.68
- HTGC 92.75
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.